Total Payments
$314,932
2024 Payments
$145,855
Companies
22
Transactions
899
Payment Breakdown by Category
Other$211,320 (67.1%)
Travel$70,877 (22.5%)
Food & Beverage$18,489 (5.9%)
Consulting$13,956 (4.4%)
Education$289.98 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $207,333 | 138 | 65.8% |
| Travel and Lodging | $70,877 | 166 | 22.5% |
| Food and Beverage | $18,489 | 582 | 5.9% |
| Consulting Fee | $13,956 | 7 | 4.4% |
| Honoraria | $3,988 | 2 | 1.3% |
| Education | $289.98 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $89,231 | 128 | $0 (2024) |
| Alkermes, Inc. | $71,652 | 128 | $0 (2024) |
| ABBVIE INC. | $66,631 | 196 | $0 (2024) |
| ITI, Inc. | $24,726 | 39 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $21,296 | 66 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $18,733 | 78 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $12,649 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,281 | 9 | $0 (2024) |
| Allergan, Inc. | $1,650 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $669.92 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145,855 | 300 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($89,231) |
| 2023 | $96,659 | 303 | ABBVIE INC. ($33,058) |
| 2022 | $46,854 | 167 | Alkermes, Inc. ($29,173) |
| 2021 | $25,564 | 129 | Neurocrine Biosciences, Inc. ($6,606) |
All Payment Transactions
899 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $78.52 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,695.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: CNS | ||||||
| 11/26/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: CNS | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $324.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | Cash or cash equivalent | $318.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $107.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $1,476.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Psychology/Psychiatric | ||||||
About Tammy Russo, NPP
Tammy Russo, NPP is a Psychiatric/Mental Health healthcare provider based in Niskayuna, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1093976003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tammy Russo, NPP has received a total of $314,932 in payments from pharmaceutical and medical device companies, with $145,855 received in 2024. These payments were reported across 899 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($207,333).
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Niskayuna, NY
- Active Since 06/23/2008
- Last Updated 09/28/2022
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093976003
Products in Payments
- CAPLYTA (Drug) $113,958
- LYBALVI (Drug) $71,448
- VRAYLAR (Drug) $68,264
- Qelbree (Drug) $15,827
- INGREZZA (Drug) $12,649
- AUSTEDO (Drug) $11,375
- Austedo XR (Drug) $9,627
- COBENFY (Drug) $4,168
- QELBREE (Drug) $2,906
- REXULTI (Drug) $605.19
- Auvelity (Drug) $515.32
- Azstarys (Drug) $410.31
- INVEGA SUSTENNA (Drug) $392.09
- LATUDA (Drug) $363.92
- TRINTELLIX (Drug) $328.10
- QUVIVIQ (Drug) $255.35
- SPRAVATO (Drug) $223.82
- JORNAY PM (Drug) $197.89
- AZSTARYS (Drug) $178.75
- NUEDEXTA (Drug) $169.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Niskayuna
Daniel Breeyear, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $52,441
Psychiatric/Mental Health $52,441
Heather Jansen, Ms, Aprn, Fpmhnp, MS, APRN, FPMHNP
Psychiatric/Mental Health — Payments: $2,569
Psychiatric/Mental Health $2,569
Alexandra Olsiewski, Npp, NPP
Psychiatric/Mental Health — Payments: $1,275
Psychiatric/Mental Health $1,275
Mrs. Anita Liddle, Npp, NPP
Psychiatric/Mental Health — Payments: $14.41
Psychiatric/Mental Health $14.41